Author:
Gross D. J.,Sidi H.,Weiss L.,Kalland T.,Rosenmann E.,Slavin S.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference27 articles.
1. Kalland T, Alm G, Standhalske T (1985) Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator. J Immunol 134:3956?3961
2. Kalland T (1990) Regulation of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level. J Immunol 144:4472?4476
3. Stalhandske T, Kalland T (1986) Effects of the novel immunomodulator LS 2616 on the delayed-type hypersensitivity reaction to Bordetella pertussis in the rat. Immunopharmacology 11:87?92
4. Larson EL, Joki A, Standhalske T (1987) Mechanisms of action of the new immunomodulator LS2616 on T-cell responses. Int J Immunopharmacol 9:425?431
5. Tarkowski A, Gunnarsson K, Stalhandske T (1986) Effects of LS-2616 administration upon the autoimmune disease of (NZB×NZW) F1 hybrid mice. Immunology 59:589?594
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metabolism Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024
2. Inhibitory Effect of Paquinimod on a Murine Model of Neutrophilic Asthma Induced by Ovalbumin with Complete Freund’s Adjuvant;Canadian Respiratory Journal;2021-03-15
3. Safety Pharmacology in Metabolism Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2013
4. Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: Studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in;Arthritis & Rheumatism;2012-04-26
5. H1521, a novel derivative of 4-hydroxyquinoline-3-carboxamide, suppresses the development of lupus in mice by inducing Th1 cytokine profile in T cells;International Immunopharmacology;2011-04